IMARC Group has recently released a new research study titled “South Korea Bioinformatics Market Size, Share, Trends and Forecast by Product and Services, Application, End Use Sector, and Region, 2025-2033, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.
Market Overview
The South Korea Bioinformatics Market size of USD 264.91 million in 2024. It is projected to grow to USD 714.21 million by 2033, registering a CAGR of 11.65% during the forecast period. This growth is driven by advancements in genomic research and personalized medicine, with increasing applications in aging-related diseases due to population aging. The market analysis covers diverse segments, including products, services, and regional insights, highlighting South Korea’s expanding demand for bioinformatics solutions.
Study Assumption Years
- Base Year: 2024
- Historical Year/Period: 2019-2024
- Forecast Year/Period: 2025-2033
South Korea Bioinformatics Market Key Takeaways
- Current Market Size: USD 264.91 million (2024)
- CAGR: 11.65%
- Forecast Period: 2025-2033
- The market is expanding due to increased investment in sequencing technologies and government initiatives supporting genomics.
- Personalized medicine demands and tailored therapies are growing, accelerating market growth.
- Population aging in South Korea is fueling needs for genomic studies targeting age-related diseases like Alzheimer’s and Parkinson’s.
- Bioinformatics tools are crucial for genetic, molecular disease understanding and biomarker discovery.
- Integration of multi-omics services by companies like Novogene Korea Ltd enhances the market’s dynamism.
Sample Request Link: https://www.imarcgroup.com/south-korea-bioinformatics-market/requestsample
Market Growth Factors
The South Korea bioinformatics market is propelled by the escalating focus on genomic research and personalized medicine. Government-backed initiatives and rising investments in sequencing technologies are central to this growth. The evolution of precision medicine demands increasingly sophisticated data-driven solutions that can handle large genomic datasets to deliver tailored treatment options. Consequently, bioinformatics has gained a pivotal role in predicting, diagnosing, and treating diseases, enhancing the healthcare system’s efficiency in South Korea.
Another key growth driver is the rapid aging of South Korea’s population, influencing bioinformatics demand profoundly. According to data from 2024, the population aged 65 and above is approximately 10.24 million, representing 20% of the total population of 51 million. This demographic shift increases the prevalence of age-related diseases such as Alzheimer’s and Parkinson’s diseases and stimulates demand for innovative preventive, diagnostic, and treatment strategies. Bioinformatics platforms enable researchers to uncover genetic vulnerabilities and biomarkers essential for developing precise interventions targeting these conditions.
Bioinformatics also accelerates drug development and clinical trials, particularly for aging-related diseases, by offering enhanced understanding and tailoring of medications. The synergy between genomics and bioinformatics fosters the creation of integrated, multi-omics services, exemplified by companies like Novogene Korea Ltd, which strengthen partnerships within Korea’s biotech and biomedical sectors. This fusion supports the expanding personalized healthcare landscape and reinforces the demand for comprehensive, data-driven bioinformatics services.
Market Segmentation
Products and Services
- Knowledge Management Tools
- Generalized Knowledge Management Tools: Tools designed to facilitate broad knowledge organization and sharing across bioinformatics applications.
- Specialized Knowledge Management Tools: Tailored tools focusing on specific expert knowledge domains within bioinformatics.
- Bioinformatics Platforms
- Surgical Simulation Platforms: Platforms that replicate surgical scenarios to aid in training and procedure planning.
- Sequence Analysis, Alignment, and Manipulation Platforms: Tools for genomic sequence processing and analysis.
- Structure and Function Analysis Platforms: Platforms analyzing molecular structures and their functions.
- Other Bioinformatics Services
- Data Analysis Services: Services focused on analyzing biological data to derive insights.
- Database Management Services: Services managing storage, retrieval, and organization of bioinformatics data.
- Other: Additional bioinformatics-related services not categorized above.
Applications
- Genomics: Study and analysis of genomes to understand genetic information.
- Chemoinformatics and Drug Design: Application of informatics in chemical data handling and drug development.
- Proteomics: Study of proteomes and protein functions.
- Transcriptomics: Examination of RNA transcripts to understand gene expression.
- Metabolomics: Analysis of metabolites within biological systems.
- Others: Additional bioinformatics application areas.
End-Use Sectors
- Medical Biotechnology: Bioinformatics applications in medical research and therapeutics.
- Academic: Research and educational uses of bioinformatics.
- Animal Biotechnology: Applications involving animal genetics and biology.
- Agricultural Biotechnology: Bioinformatics in crop and farm animal enhancement.
- Environmental Biotechnology: Use in environmental science and ecology.
- Forensic Biotechnology: Application in legal and forensic sciences.
- Others: Other sectors utilizing bioinformatics.
Ask For an Analyst- https://www.imarcgroup.com/request?type=report&id=39752&flag=C
Regional Insights
The report categorizes the market across key regions including Seoul, Capital Area, Yeongnam (southeast), Honam (southwest), Hoseo (central), and others. The Capital Area, particularly Seoul, is a dominant region, with South Korea’s dynamic biotech industry and emerging companies fueling demand. Detailed market shares and growth statistics by region are not provided explicitly.
Recent Developments & News
In July 2025, the International Conference on Bioinformatics and Computational Molecular Biology (ICBCMB-25) will be held in Seoul on the 25th and 26th, gathering global experts to discuss innovations in science and bioinformatics. Selected papers will be published in Scopus or Web of Science indexed journals.
Also in July 2025, Innocrace expanded its whole genome sequencing (WGS)-based cancer diagnostic platform “CancerVision” to 10 hospitals in South Korea. This platform uses bioinformatics for precision detection of complex mutations, underscoring the clinical adoption of genomics and bioinformatics in oncology.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
Tel No: (D) +91 120 433 0800,
United States: +1-201971-6302